Congress quietly extends regulatory relief for billion-dollar startups
H.R. 3323 — Helping Startups Continue To Grow Act · Filed by Bryan Steil (R-WI) · 2 cosponsors · Introduced May 13, 2025 · Reported out
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill raises the revenue threshold for 'emerging growth companies' from $1 billion to $3 billion and extends the period during which they qualify for reduced regulatory burdens from 5 years to 10 years. Emerging growth companies face lighter disclosure and auditing requirements under federal securities law; the bill makes it easier for larger, longer-lived startups to retain that lighter regulatory treatment.
Why we flagged it
The bill's sole operative mechanism is to expand and extend the emerging growth company exemption—a regulatory carve-out that reduces disclosure, audit, and compliance burdens. It is a straightforward deregulatory measure, not a hidden rider or complex restructuring.
What the text implies
- Companies with $1B–$3B in revenue can now claim emerging growth status for up to 10 years instead of 5, delaying the point at which they must comply with full Sarbanes-Oxley auditing and disclosure standards.
- Investors in these larger, longer-lived companies will receive less frequent and less rigorous financial audits, potentially masking deteriorating financial conditions or accounting irregularities.
The full analysis lists 4 implications of this text.
Who stands to gain
growth-stage private companies with $1B–$3B revenue; venture capital and private equity firms (portfolio companies face lower compliance costs); accounting and audit firms (reduced audit scope = lower costs for clients)